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SUMMARY 8 
Ion channel complexes promote action potential initiation at the mammalian axon initial 9 
segment (AIS), and modulation of AIS size by recruitment or loss of proteins can influence 10 
neuron excitability. Although endocytosis contributes to AIS turnover, how membrane 11 
proteins traffic to this proximal axonal domain is incompletely understood. Neurofascin186 12 
(Nfasc186) has an essential role in stabilising the AIS complex to the proximal axon, and 13 
the AIS channel protein Kv7.3 regulates neuron excitability. Therefore, we have studied 14 
how these proteins reach the AIS. Vesicles transport Nfasc186 to the soma and axon 15 
terminal where they fuse with the neuronal plasma membrane. Nfasc186 is highly mobile 16 
after insertion in the axonal membrane and diffuses bidirectionally until immobilized at the 17 
AIS through its interaction with AnkyrinG. Kv7.3 is similarly recruited to the AIS. This study 18 
reveals how key proteins are delivered to the AIS and thereby how they may contribute to 19 
its functional plasticity. 20 
INTRODUCTION 21 
 2 
Neurons are highly polarised cells with functionally distinct membrane domains. The axon 22 
initial segment (AIS) is located at the proximal part of the axon where the high density of 23 
voltage-gated sodium channels (Nav) promotes the initiation and propagation of nerve 24 
impulses (Leterrier, 2018, Palay et al., 1968). After AIS assembly during development, this 25 
domain can retain a degree of plasticity such that changes in its size and length can 26 
influence neuronal excitability in the mature nervous system (Grubb et al., 2011, Petersen 27 
et al., 2017, Kuba, 2012). This morphological plasticity reflects the ability of the AIS to 28 
change the amount of its constituent proteins rather than their density (Evans et al., 2015). 29 
However, whether membrane proteins are exclusively inserted directly into the AIS as 30 
AnkG/membrane protein complexes (Leterrier et al., 2017), are concentrated at the AIS by 31 
selective endocytosis, or primarily arrive by lateral diffusion in the membrane from other 32 
insertion sites, or indeed whether all three mechanisms apply remains uncertain (Akin et 33 
al., 2015, Barry et al., 2014, Boiko et al., 2007, Brachet et al., 2010, Fréal et al., 2019, 34 
Hamdan et al., 2020, Leterrier et al., 2017, Nakada et al., 2003, Torii et al., 2020, Winckler 35 
et al., 1999, Yap et al., 2012, Zonta et al., 2011). Hence, determining the pathways by 36 
which membrane proteins are delivered to the AIS is not only important for understanding 37 
nervous system development, but may also shed light on how excitability is modulated in 38 
the mature neuron. 39 
Neurofascin186 (Nfasc186) is a transmembrane protein with an essential role in 40 
maintaining the intactness of the AIS complex and in restricting AIS proteins to this 41 
specialized domain (Alpizar et al., 2019, Boiko et al., 2007, Jenkins and Bennett, 2001, 42 
Zonta et al., 2011). Deletion of Nfasc186 in culture and in vivo causes the disintegration of 43 
the AIS with the loss of Nav, AnkG, IV-Spectrin and Nr-CAM; the consequent disordered 44 
electrophysiology impairs motor learning (Alpizar et al., 2019, Zonta et al., 2011).  45 
 3 
In this study we show that vesicles transport Nfasc186 to two spatially distinct locations 46 
in cortical neurons, the cell soma and the axon terminus, where they fuse with the 47 
neuronal membrane. Analysis by fluorescence recovery after photobleaching (FRAP) 48 
combined with fluorescence loss in photobleaching (FLIP) shows that Nfasc186 is highly 49 
mobile in the neuronal membrane and that lateral diffusion in the axon, both proximally 50 
and distally to the AIS from the soma and axon terminal respectively, is primarily 51 
responsible for Nfasc186 delivery to the AIS. Unlike Nav1.6, direct fusion of transport 52 
vesicles at the proximal axon does not contribute to the accumulation of Nfasc186 at the 53 
AIS (Akin et al., 2015).  Interaction with AnkG immobilises Nfasc186 at the AIS but is 54 
unnecessary for the incorporation of the protein into the axonal membrane. Kv7.3 also 55 
interacts with AnkG (Pan et al., 2006, Zhang et al., 1998) and follows a similar route to the 56 
AIS (Devaux et al., 2004, Pan et al., 2006, Rasmussen et al., 2007, Shah et al., 2008).  57 
 58 
RESULTS and DISCUSSION 59 
Nfasc186 is inserted into the neuronal membrane at the soma and axon terminus  60 
Nfasc186 is transported in vesicles generated in the secretory pathway by microtubule-61 
based fast axonal transport, which is probably Kinesin 1-dependent (Barry et al., 2014, 62 
Bekku and Salzer, 2020, Fréal et al., 2019, Ichinose et al., 2019, Thetiot et al., 2020). In 63 
order to image the pathway by which these vesicles reach the neuronal plasma 64 
membrane, we expressed super-ecliptic pHluorin (SEP) fused to the extracellular domain 65 
of full-length Nfasc186 in cortical neurons. SEP is a pH-sensitive GFP-derivative that 66 
allows selective imaging of Nfasc186 expressed at the cell surface (Ashby et al., 2004, 67 
Ashby et al., 2006, Hildick et al., 2012, Makino and Malinow, 2009, Martin et al., 2008, 68 
Wilkinson et al., 2014).  69 
 4 
First, we asked if SEP-Nfasc186 is accumulated at the AIS like endogenous 70 
Neurofascin. Enrichment of the fusion protein at the AIS relative to the soma or distal axon 71 
was not significantly different from that of endogenous neuronal Nfasc186, either on a wild 72 
type (WT) or a Neurofascin-null background (Figures 1A and 1B). We then wished to 73 
identify the earliest stages of its journey to the AIS. Hence, neurons were transfected at 74 
DIV 2, and imaged the next day prior to AIS formation. SEP-Nfasc186 was strongly 75 
expressed at the cell surface of the soma and axon terminal (Figure 1C). Coexpression of 76 
KHC560-halo confirmed the axon terminal as a primary location of SEP-Nfasc186 77 
accumulation at the cell surface (Figure 1C) (Twelvetrees et al., 2016). A line scan of SEP-78 
Nfasc186 signal intensity at the cell soma, axon and axon terminal of the neuron in the 79 
upper panel of Figure 1C showed that fluorescence was readily detectable in the axonal 80 
membrane relative to background (Figure 1D). Neither the absence of the over-expressed 81 
kinesin nor reduced Nfasc186 expression on a Neurofascin-null background influenced the 82 
localisation of SEP-Nfasc186 (Figure 1-figure supplement 1A and 1B), and 83 
immunostaining using an antibody against an extracellular domain of the endogenous 84 
protein revealed Nfasc186 at the membrane surface of the soma and the axon terminus as 85 
found for SEP-Nfasc186 (Figure 1-figure supplement 1C). We concluded that SEP-86 
Nfasc186 is a suitable proxy for assessing the localisation of endogenous neuronal 87 
Neurofascin. 88 
 89 
  90 
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Figure 1. 91 
 92 
 93 
SEP-Nfasc186 accumulates at the AIS and the cell surface of the soma and axon terminus before 94 
the formation of the AIS. 95 
(A) Immunostaining of cortical neurons at DIV 7 shows that SEP-Nfasc186 is delivered to the AIS where it 96 
colocalises with ßIV-Spectrin. Location of the cell body is shown by asterisks. Scale bar, 10 µm. (B) 97 
Quantitation of signal intensity shows comparable enrichment of SEP-Nfasc186 relative to either the soma 98 
or distal axon when compared to endogenous Neurofascin irrespective of expression in WT or Neurofascin 99 
null neurons. n=3, ≥ 41 cells; one-way ANOVA; ns = not significant. (C) Live imaging before AIS formation 100 
at DIV 3 shows SEP-Nfasc186 at the surface of the soma and axon terminus (arrows). KHC560-halo 101 
identifies the axon terminus. Dashed lines outline the axon. Scale bar, 10 µm. (D) Line scan of top panel in 102 
C showing the SEP-Nfasc186 signal intensity in the cell body, axon and terminal relative to background.  103 




Figure 1—figure supplement 1.  107 
SEP-Nfasc186 expressed in Neurofascin-null neurons and endogenous Neurofascin in WT cells 108 
accumulate at the cell surface of the soma and axon terminus before the formation of the AIS.  109 
(A) SEP-Nfasc186 was transfected at DIV 2 in Neurofascin-null cortical neurons. The expression at DIV 3 110 
shows enrichment at the cell surface membrane of the soma and axon terminal (arrows). Scale bar, 10 µm.  111 
(B) Line scan of A showing SEP-Nfasc186 signal intensity in the cell body, axon and terminal relative to 112 
background. (C) The surface staining of neuronal Neurofascin (Nfasc) using an antibody directed to the 113 
extracellular domain of Nfasc186 at DIV 2 shows increased signal intensity at the soma and axon terminal 114 
(inset), Phalloidin staining identifies the cell body and the axon terminal (inset of axon terminal). Scale bar 5 115 
µm. 116 
  117 
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Live imaging revealed transient increases in the fluorescent intensity of SEP-Nfasc186 118 
at the surface of the axon terminal suggesting possible exocytotic fusion events. (Figure 119 
2A). Total internal reflection fluorescence (TIRF) microscopy can reveal the sites of 120 
exocytotic fusion of vesicles that transport SEP-fusion proteins in neurons (Li et al., 2012). 121 
TIRF analysis showed that surface delivery of SEP-Nfasc186 is particularly active at the 122 
cell body and axon terminus, but not at the axon itself (Figure 2B and 2C; Video 1). The 123 
periodic actin/spectrin axonal cytoskeleton may play a role in limiting exocytotic events in 124 
the axon (Leterrier, 2018). 125 
  126 
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Nfasc186 is inserted into the neuronal membrane by vesicular fusion at the soma and axon 131 
terminus.  132 
(A) Still video images show transient elevated signal intensities (arrows) of SEP-Nfasc186 at the cell 133 
surface of an axon terminal. Scale bar, 5 µm. (B) TIRF microscopy reveals exocytotic insertion of SEP-134 
Nfasc186 at the cell membrane of the soma and axon terminal (boxes), see Video 1. The soma, axon and 135 
terminal are outlined with dashed lines. Scale bar, 5 µm. (C) Quantitation of vesicle fusion events. Number 136 
of cells; soma = 4, axons = 7, terminal = 5. 137 
  138 
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Lateral diffusion of Nfasc186 in the axonal membrane 139 
In order to ask if Nfasc186 can move retrogradely from the axon terminal in the axon 140 
membrane or if it remains at the axon terminal and is simply retrogradely transported back 141 
to the soma by vesicular transport, we adopted two approaches. First, neurons were 142 
transfected at DIV 3-4 and the lateral mobility of SEP-Nfasc186 in the axonal membrane 143 
was analysed ~16 h later after subjecting a region of the axon immediately proximal to the 144 
axon terminus to continual bleaching by Fluorescence Loss in Photobleaching (FLIP) 145 
(Figure 3A; Video 2). Imaging of a control region of the axon showed no diminution in 146 
overall fluorescence signal during the experiment (Figure 3A-C; Video 2). Loss of SEP-147 
Nfasc186 signal proximal to the region of interest (ROI) indicated that SEP-Nfasc186 148 
moves laterally in the axonal membrane from the axon terminus (Figure 3A-C; Video 2). 149 
Furthermore, since FLIP does not bleach vesicular SEP-Nfasc186, the loss of signal 150 
intensity at the axon terminal apparent in Figure 3A shows that diffusion of SEP-Nfasc186 151 
in the axon membrane is bidirectional and can also occur anterogradely, as confirmed by 152 
asymmetric FLIP at the AIS with reference to Figure 4 (see below). 153 
Further evidence for the retrograde diffusion of Nfasc186 in the axonal membrane from 154 
the axon terminus came from photoconversion of Nfasc186-Dendra2. Photoconversion of 155 
Dendra2 from a green to a red state permits the tracking of protein movements in live cells 156 
(Chudakov et al., 2007). Photoconverted Nfasc186-Dendra2 in the axon terminal moved 157 
retrogradely in the distal axon (Figure 3D, and Video 3).  158 
Video analysis of vesicles transporting Nfasc186-mCh shows their extensive 159 
anterograde and retrograde movement (Video 4). This is also evident for vesicles 160 
transporting Nfasc186-Dendra2 and kymographic analysis of their movement immediately 161 
proximal to the axon terminal showed that although nocodazole strongly inhibited vesicular 162 
transport of Nfasc186-Dendra2 (Figure 3-figure supplement 1A and 1B), it had no effect on 163 
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the retrograde movement of photoconverted Nfasc186-Dendra2 (Figures 3D and 3E; 164 
Video 3). Hence, the signal arising from the retrograde movement of photoconverted 165 
Nfasc186-Dendra2 visualized in the axon primarily reflects fluorescence from cell surface 166 
protein. In summary, Nfasc186 is extremely mobile after insertion in the neuronal 167 
membrane and can move towards the AIS in the plane of the axonal membrane. 168 
To determine if delivery and retrograde diffusion from the axon terminal was unique to 169 
Nfasc186, we studied another AIS protein, the potassium channel Kv7.3. The fusion 170 
protein SEP-Kv7.3 shows a similar pattern of enrichment and delivery to the neuronal 171 
membrane at the cell body and axon terminus before the formation of the AIS (Figure 3-172 
figure supplement 2A-C). Furthermore, FLIP at the axon immediately proximal to the axon 173 
terminal showed that Kv7.3 also undergoes retrograde movement from the axon terminus 174 
in the axonal membrane (Figure 3-figure supplement 2D-F).  175 
Next, we wished to ask three questions: how mobile is SEP-Nfasc186 in the axonal 176 
membrane, is this mobility influenced by the axonal cytoskeleton and is the mobility of the 177 
protein changed at the AIS? 178 
  179 
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Figure 3. 180 
 181 
 182 
Lateral movement of Nfasc186 in the axon membrane from the axon terminal towards the distal 183 
axon.  184 
(A-C) Still images and quantitation from Video 2 show depletion of SEP-Nfasc186 signal (arrowheads) 185 
proximal to the ROI after FLIP proximal to the axon terminal and at the axon terminal itself. In the Imaging 186 
control axons were subjected to the same acquisition protocol without FLIP. n=3; ≥ 15 cells. Scale bar, 10 187 
µm. (D-E) Still images from Video 3 of the photoconversion of Nfasc186-Dendra2 in the axon terminal and 188 
quantitation of normalised signal intensities (ROI boxes with insets) show that nocodazole does not affect 189 
Nfasc186-Dendra2 movement into the axon. An image in the green channel before photoconversion is 190 
shown in the top panel and the irradiated area is outlined in the dashed circle. n = 3, ≥ 14 cells. Scale bar, 191 











Figure 3—figure supplement 1.  202 
Nocodazole inhibits the movement of vesicles transporting Nfasc186-Dendra2. 203 
(A) Intra-axonal vesicles containing Nfasc186-Dendra2 were readily identifiable immediately proximal to the 204 
axon terminal and kymographs of their motion showed that their movement was arrested in distal axons by 205 
nocodazole. Scale bar, 5 µm. (B) Mean velocities of anterograde and retrograde axonal vesicles were 206 
measured from kymographs. n = 5 axons. One-way ANOVA followed by Tukey’s multiple comparison test. 207 
****P < 0.0001. **P < 0.01. 208 
  209 




Figure 3—figure supplement 2.  213 
Kv7.3 accumulates at the soma and axon terminus before the formation of the AIS.  214 
(A) Live imaging of a neuron at DIV 3 showing accumulation of SEP-Kv7.3 at the membrane surface of the 215 
soma and axon terminus (arrows). KHC560-halo identifies the axon terminus. SEP-Kv7.3 is co-expressed 216 
with Kv7.2. Dashed lines outline the axon. Scale bar, 20 µm. (B) Line scan of the first panel in A showing the 217 
SEP-Kv7.3 signal intensity in the cell body, axon and terminal relative to background. (C) Still video images 218 
show SEP-Kv7.3 at the cell surface of the axon terminal and arrows indicate transient elevated signal 219 
intensities. Scale bar, 5 µm. (D-F) Still images from a time-lapse video and quantitation of fluorescence 220 
intensity show that repetitive photobleaching (FLIP) of the ROI (box) at the axon immediately proximal to the 221 
axon terminal causes depletion of SEP-Kv7.3 signal (arrowheads) proximal to the ROI and at the axon 222 
terminal. (D) In a control region of the axon no change in signal intensity was observed for the duration of the 223 
experiment in the absence of FLIP (imaging control). Data are mean ± SE. n ≥ 8 axons. Scale bar, 10 µm. 224 
  225 
  226 
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Highly mobile Nfasc186 is delivered to the AIS by lateral diffusion in the axonal 227 
membrane  228 
FRAP showed not only that SEP-Nfasc186 was highly mobile in the distal axonal 229 
membrane but also that its mobility was unaffected by either the inhibition of myosin II 230 
ATPase activity with blebbistatin or disruption of microfilaments with latrunculin A (Figures 231 
4A and 4B) (Berger et al., 2018, Sobotzik et al., 2009). Hence, Nfasc186 can diffuse from 232 
the somatic or axon terminal plasma membrane to the AIS unassisted by the underlying 233 
cytoskeleton or its associated motor proteins (see also Figure 3D). The diffusion coefficient 234 
for Nfasc186 in the distal axon is 0.37 ± 0.01 µm2/s and is comparable to the previously 235 
reported value for highly mobile, untethered axonal Nfasc186 (0.34 ± 0.02 µm2/s)  (Zhang 236 
et al., 2012). 237 
Nfasc186 stabilises the mature AIS (Zonta et al., 2011) but in order to monitor the 238 
trafficking of newly synthesised Nfasc186, when AIS assembly is at an early stage, we 239 
assessed Nfasc186 mobility at the AIS at DIV 5-6 and later at DIV 12-13, approximately 36 240 
h after transfection in each case (Figure 4C and 4D). Accumulation of SEP-Nfasc186 at 241 
the soma and axon terminal continued during AIS assembly (Figure 4-figure supplement 242 
1). Maturation of the AIS was accompanied by a significant reduction in the mobility of 243 
SEP-Nfasc186 (recovery 46.1 ± 0.8 % and 34.3 ± 1.6 %, respectively). In order to focus on 244 
the earlier stages of Nfasc186 recruitment, all subsequent studies on the AIS of cortical 245 
neurons were performed at DIV 3-6. 246 
Since SEP-Nfasc186 was highly mobile in the axon membrane outside the AIS but 247 
much less mobile upon entry into the AIS, we wished to determine if the mobile pool 248 
contributed to the accumulation of Nfasc186 in the AIS. We combined FRAP with FLIP to 249 
determine the contribution by lateral diffusion of highly mobile protein to fluorescence 250 
recovery in the AIS since continual FLIP at regions flanking the FRAP ROI should 251 
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selectively prevent fluorescence recovery by lateral ingress of fluorescent SEP-Nfasc186 252 
at the AIS surface. FRAP-FLIP also permitted evaluation of the extent of direct fusion of 253 
axonal vesicles containing SEP-fusion proteins to fluorescence recovery at the AIS 254 
membrane surface since intra-axonal, vesicular SEP-Nfasc186, where the SEP 255 
fluorophore projects into the vesicular lumen, is neither fluorescent nor susceptible to 256 
continual photobleaching by FLIP: hence, any recovery in fluorescence must be due to 257 
vesicular fusion (Figure 4-figure supplement 2A) (Ashby et al., 2004, Ashby et al., 2006, 258 
Hildick et al., 2012, Makino and Malinow, 2009, Martin et al., 2008, Wilkinson et al., 2014).  259 
FRAP revealed substantial recovery of fluorescence within the AIS: however, this 260 
recovery is abolished by FLIP (Figures 4E and 4F; Video 5).  We concluded that recovery 261 
of fluorescence is due to lateral movement of SEP-Nfasc186 in the axonal membrane with 262 
no significant contribution from direct vesicular fusion. By performing asymmetric FLIP on 263 
just one side of the ROI instead of bilaterally we were able to show that lateral diffusion of 264 
SEP-Nfasc186 into the AIS was bidirectional (recovery: 13.2 ± 0.2 %-distal FLIP; 11.9 ± 265 
0.7 %-proximal FLIP; mean ± SEM, n = 3, Student’s t test, not significant).  266 
To confirm that the fate of SEP-Nfasc186 at the AIS was not influenced by the presence 267 
of excess endogenous Nfasc186 we also performed FRAP-FLIP on cortical neurons 268 
derived from Neurofascin-null mice and obtained similar results (Figure 4-figure 269 
supplement 2B and 2C). We conclude that fusion of Nfasc186 transport vesicles and 270 
concomitant protein insertion at the AIS itself is not a substantial source of surface-271 
expressed AIS Nfasc186 in cortical neurons. In contrast, bidirectional lateral diffusion in 272 
the axonal membrane is the dominant mechanism by which Nfasc186 enters the AIS. 273 
Discriminating between lateral diffusion and vesicular fusion as contributors to the 274 
recovery of fluorescence signal after FRAP-FLIP depends on the fact that not only is 275 
fluorescence emission from intra-axonal SEP-vesicular protein eclipsed, but also that this 276 
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population is not susceptible to bleaching or photochemical damage. Several previous 277 
studies have shown these assumptions to be correct (Ashby et al., 2004, Ashby et al., 278 
2006, Hildick et al., 2012, Makino and Malinow, 2009, Martin et al., 2008, Wilkinson et al., 279 
2014). Nevertheless, we wished to confirm that SEP does indeed report Nfasc186 280 
exclusively at the neuronal surface (Figure 4-figure supplement 3A), and, using a refined 281 
protocol, we confirmed that intra-axonal vesicular SEP-Nfasc186 is neither fluorescent nor 282 
susceptible to photobleaching (Figure 4-figure supplement 3B-F).  283 
In order to extend the conclusions from these data to other neuronal cell types, we 284 
asked if Nfasc186 is recruited to the AIS of neurons in an organotypic preparation by 285 
lateral diffusion. We have previously established that Nfasc186 has an essential role in 286 
stabilizing the AIS of Purkinje cells in vivo (Zonta et al., 2011). FRAP-FLIP analysis of 287 
acute cerebellar slices from P10 transgenic mice showed that fluorescence recovery at the 288 
Purkinje cell AIS was indeed by lateral diffusion in the plane of the axonal membrane, as 289 
found for cortical neurons (Figure 4-figure supplement 4A-D). 290 
  291 
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Figure 4. 292 
 293 
 294 
Nfasc186 is delivered to the AIS by lateral diffusion in the cell membrane of cortical neurons.  295 
(A—B) Cultured cortical neurons were treated with the myosin ATPase inhibitor blebbistatin and latrunculin A. The 296 
FRAP curves show that the drugs did not affect recovery of the mean signal intensity from three independent 297 
experiments for each condition. The bar graph shows the mean recovery fraction. n = 3, ≥ 16 cells; Student’s t test; ns 298 
= not significant. (C-D) Comparison of FRAP curves at DIV 5-6 and DIV 12-13 shows that SEP-Nfasc186 becomes 299 
significantly more immobilized at the AIS with time. n = 3, ≥ 17 cells. Student’s t test. **P < 0.01. (E-F). Still images 300 
from Video 5 of FRAP and FRAP-FLIP within the AIS (FRAP at boxed ROIs and FLIP at flanking boxed ROIs) and 301 
quantitation show that signal recovery after photobleaching is prevented by FLIP. n = 3, ≥ 16 cells; Student’s t test; ***P 302 





Figure 4—figure supplement 1. 307 
Enrichment of SEP-Nfasc186 at the soma and axon terminal during AIS assembly. 308 
(A) Live imaging of a cortical neuron expressing both SEP-Nfasc186 and AnkG-mCherry fusion proteins (see 309 
Figure 4—figure supplement 3) (grey scale, SEP; magenta, mCherry) shows that SEP-Nfasc186 and 310 
AnkG-mCherry are enriched at the AIS at DIV 5. (B) Line scans show SEP-Nfasc186 enrichment at the AIS 311 





Figure 4—figure supplement 2.  316 
SEP-Nfasc186 is delivered to the AIS by lateral diffusion in Neurofascin null cortical neurons.  317 
(A) Schematic of FRAP and FRAP-FLIP. (B) FRAP and FRAP-FLIP at the AIS (FRAP at boxed ROIs and 318 
FLIP at flanking boxed ROIs). Still images show signal recovery after photobleaching is prevented by FLIP. 319 
(C) Quantitation of fluorescence signal recovery after FRAP and FRAP-FLIP. n=2, ≥ 9 cells. Student’s t test.  320 
**P < 0.01. Scale bar, 2 µm. 321 
  322 




Figure 4—figure supplement 3.  326 
Control experiment to show that the vesicular fraction of SEP-Nfasc186 is not bleached during FRAP-FLIP.  327 
(A) Diagram of the SEP-Nfasc186 and AnkG-mCherry (AnkG-mCh) fusion proteins showing the sites of the fluorescent 328 
reporter attachment (green, SEP; magenta, mCh). Live imaging of a cortical neuron expressing both proteins shows that 329 
SEP-Nfasc186 and AnkG-mCh are enriched at the AIS. Brief (less than 1 min) exposure to an acidic medium (pH 6.0) 330 
quenched SEP-Nfasc186 fluorescence. Hence, SEP-Nfasc186 fluorescence originates primarily from the surface-331 
expressed protein. The subsequent alkalinisation with NH
4
Cl restores the surface signal and reveals intracellular vesicles 332 
(arrowheads). Asterisks show the position of the cell body. Scale bar, 10 µm. (B) Surface and total fluorescence signal 333 
intensity after alkalinisation of SEP-Nfasc186. The difference between surface and total fluorescence intensity shows the 334 
fluorescence contribution from vesicular SEP-Nfasc186 without FRAP-FLIP. (n = 9 cells). (C) Mean recovery of surface 335 
signal intensity after FRAP-FLIP (n = 7 cells). (D) Mean recovery of surface signal intensity after FRAP-FLIP and 336 
subsequent alkalinisation (total, n =7 cells). (E) Computation from C and D of surface and total signal intensity of SEP-337 
Nfasc186 after FRAP-FLIP to calculate the vesicular intensity after FRAP-FLIP. (F) Comparison of vesicular signal 338 
intensity without and with FRAP-FLIP (from B and E) shows that FLIP did not affect any potential contribution from 339 
vesicular SEP-Nfasc186 to fluorescence recovery at the cell surface. All fluorescence signal intensities were normalized 340 
to surface signal intensities (without NH
4
Cl). Student’s t test; ns = not significant. 341 





Figure 4—figure supplement 4.  346 
Nfasc186 is recruited to the AIS by lateral diffusion in cerebellar Purkinje Neurons.  347 
(A) Immunofluorescence staining of Purkinje cells at P10 in acute cerebellar slices shows that SEP-348 
Nfasc186 expression (GFP) under the control of the L7 promoter colocalises with AnkG (AnkG) at the AIS 349 
(arrows). Immunofluorescence staining of endogenous neuronal neurofascin (Nfasc) in a WT shows that the 350 
localisation of SEP-Nfasc186 mirrors that of the endogenous protein at both the Purkinje cell somatic plasma 351 
membrane and the AIS (arrows). Scale bar, 10 µm. (B-D) Still video images of FRAP and bilateral FRAP-352 
FLIP at the AIS of live Purkinje cells in acute cerebellar slices (FRAP at boxed ROIs and FLIP at flanking 353 
boxed ROIs) show that signal recovery by FRAP is prevented by FLIP. n=3, ≥ 16 cells; Student’s t test; ***P 354 
< 0.001. Scale bar, 10 µm. 355 
  356 
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AnkG immobilizes Nfasc186 at the AIS but is not required for Nfasc186 delivery to 358 
the axonal membrane  359 
AnkG is believed to act as a pioneer constituent and key organizer of the nascent AIS 360 
(Dzhashiashvili et al., 2007, Galiano et al., 2012, Hedstrom et al., 2008, Jenkins and 361 
Bennett, 2001). Numerous studies have emphasized the importance of the interaction of 362 
Nfasc186 with AnkG at the AIS and we confirmed that mutation of the AnkG binding site 363 
prevents SEP-Nfasc186YA accumulation at the AIS (Boiko et al., 2007, Davis and 364 
Bennett, 1994, Fréal et al., 2019, Lemaillet et al., 2003, Zhang et al., 1998, Zonta et al., 365 
2011) (Figure 4-figure supplement 5A-C). FRAP confirmed that the mutant protein was 366 
indeed highly mobile at the AIS of cortical neurons (Figure 4-figure supplement 5D-F). 367 
Nevertheless, the accumulation and insertion of Nfasc186 at the surface membrane of the 368 
axon terminal does not require interaction with AnkG (Figure 4-figure supplement 5G). 369 
Hence, neither the insertion of Nfasc186 into the neuronal membrane nor its mobility in the 370 
axonal membrane requires the cotransport of an AnkG/AIS membrane protein complex. 371 
Further, although the fractional recovery of SEP-Nfasc186 at the AIS declined between 5-372 
6 and 12-13 days in culture (Figure 4D), the AnkG binding mutant of Nfasc186 retained 373 
high mobility (recovery 78.6 ± 2.0 % and 79.1 ± 1.5 %, respectively) during the same 374 
period (Figure 4-figure supplement 5E-F). This shows that as Nfasc186 becomes 375 
increasingly immobilized during the early stages of AIS formation (Figure 4C), it is the 376 
interaction of Nfasc186 with AnkG that is overwhelmingly important in anchoring and 377 
immobilizing Neurofascin at the surface of the AIS.  378 
 379 




Figure 4—figure supplement 5.  383 
AnkG immobilises Nfasc186 at the AIS by its interaction with AnkG but delivery to the axon terminal surface is 384 
independent of AnkG.  385 
(A) Mutation of the tyrosine residue in the cytoplasmic FIGQY domain of SEP-Nfasc186 generates the AnkG binding 386 
mutant SEP-Nfasc186YA. (B-C) Neurons were cotransfected at DIV 3 and imaged live at DIV 5. SEP-Nfasc186 was 387 
clustered in the AIS but SEP-Nfasc186YA was not (arrows). AnkG-mCh clustering was unaffected. The mutant showed 388 
increased accumulation at the soma (arrowheads). Scale bars, 10 m. Quantitation of signal intensity profiles show the 389 
different enrichments for SEP-Nfasc186 and the mutant at the AIS. n = 3, ≥ 28 cells. (D) Still video images show rapid 390 
recovery of fluorescence signal intensity by SEP-Nfasc186YA at DIV 5 in the AIS after photobleaching at the boxed 391 
ROI. Scale bar, 5 µm. (E-F) FRAP analysis shows that the mutant remains highly mobile at the AIS in culture up to DIV 392 
12-13 (n = 3, ≥ 17 cells). Student’s t-test; ns = not significant. (G) Still video images show that SEP-Nfasc186YA is 393 
delivered to the cell surface of the axon terminal. Arrows indicate transient elevated signal intensities. Scale bar, 5 µm.  394 
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The routes by which Nfasc186 is recruited to the AIS are depicted in a model shown in 395 
Figure 4G. Our model indicates that vesicles that transport Nfasc186 are able to fuse not 396 
only with the somatic plasma membrane but also distally to the axon terminal membrane, 397 
but they do not insert Nfasc186 at the AIS directly. Since Nfasc186  has a major role in 398 
assembling the node of Ranvier in myelinated axons, this model of sequential membrane 399 
delivery and clustering may also inform studies on how transmembrane proteins are 400 
recruited to the node (Davis et al., 1996, Sherman et al., 2005, Tait et al., 2000, Zhang et 401 
al., 2012, Zonta et al., 2008). 402 
 403 
  404 
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MATERIALS AND METHODS 405 
 406 
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Animal work was performed according to UK legislation (Scientific Procedures) 409 
Act 1986 and the guidelines of the University of Edinburgh Ethical Review policy. The 410 
generation of Nfasc-/- mice has been described (Sherman et al., 2005). To generate SEP-411 
Nfasc186 transgenic mice a SEP-Nfasc186 transgene was constructed by inserting a 412 
restriction site (Age I) by site-directed mutagenesis in the murine Nfasc186 cDNA (Zonta 413 
et al., 2008) at amino acid 38 between the signal sequence and the first IgG domain. 414 
Super-ecliptic pHluorin (SEP) cDNA (a gift from Dr. Gero Miesenböck, University of 415 
 28 
Oxford) was cloned into the Age I site and then inserted into a plasmid containing the 416 
cerebellar Purkinje cell-specific L7 promoter (Oberdick et al., 1990). Transgenic mice were 417 
generated by pronuclear injection as described (Sherman and Brophy, 2000). All mice 418 
were backcrossed to a C57BL/6 background for at least 10 generations. 419 
 420 
Cortical neuron culture 421 
Primary cortical neurons were prepared from postnatal day P0-P1 Sprague-Dawley 422 
rats irrespective of sex. Cortices were isolated and meninges were removed; the 423 
tissue was dissociated using an enzymatic solution of papain (45 U/ml; Worthington 424 
Biochemical Corp.), L-cysteine (0.2 mg/ml; Sigma-Aldrich) and DNase I (0.40 mg/ml; 425 
Sigma-Aldrich) for 15 min at 37˚C. The reaction was stopped by adding Ovomucoid 426 
protease inhibitor (1 µg/ml; Worthington Biochemical Corp.). Thereafter, neurons 427 
were dissociated in seeding media containing DMEM (Gibco, Life Technologies) 428 
supplemented with 10% fetal bovine serum (FBS, Gibco, Life Technologies), 1% 429 
GlutaMAX (Gibco, Life Technologies) and 1% penicillin/streptomycin (Sigma- 430 
Aldrich). Prior to dissection, 35 mm glass-bottom dishes (ibidi, MatTek) and 13 mm glass 431 
coverslips (VWR) were coated with poly-D-lysine (100 µg/ml; Sigma-Aldrich) overnight. 432 
Neurons were seeded at a density 60,000 cells/100 µl in culture medium. After 2 h, the 433 
medium was changed to Neurobasal medium (Gibco, Life Technologies), supplemented 434 
with 2% B-27, 1% GlutaMAX and 1% penicillin/streptomycin. 5-fluoro-2’-deoxyuridine (10 435 
µM, Sigma-Aldrich) was added to cultured neurons to inhibit the growth of non-neuronal 436 
cells. The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2. 437 
 438 
Organotypic cerebellar slice culture 439 
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Brains from L7-SEP-Nfasc186 transgenic mice at postnatal day P9–P10 were placed in 440 
ice-cold Hank's Balanced Salt Solution (HBSS; Gibco), supplemented with glucose (5 441 
mg/ml; Gibco) and 1% penicillin/streptomycin. The meninges and forebrain were 442 
immediately removed. Parasagittal cerebellar slices (100 μm) were cut using a Vibratome 443 
(Leica VT-1000S) and placed in culture medium composed of 50% MEM (Gibco), 25% 444 
HBSS, 25% heat-inactivated horse serum (Sigma-Aldrich), glucose (5 mg/ml), 1% 445 
GlutaMAX and 1% penicillin/streptomycin. The slices were transferred to the membrane of 446 
30 mm cell culture insert (Millicell, Millipore) on prewarmed medium and were maintained 447 
at 37°C in a humidified atmosphere containing 5% CO2. Live imaging was performed after 448 
3-4 h in Hibernate-A-Low Fluorescence medium (BrainBits) supplemented with 2% B27 449 
and 1% GlutaMAX (Hibernate-A imaging medium). 450 
 451 
DNA constructs and transfection                                                                        452 
SEP-Nfasc186 was subcloned into the mammalian expression vector pCMV5a. The 453 
ankyrin G binding mutant of Nfasc186, SEP-Nfasc186YA, was generated by site-directed 454 
mutagenesis of the conserved FIGQY domain to FIGQA (Boiko et al., 2007, Zhang and 455 
Bennett, 1998). To generate the Nfasc186-mCh construct, mCherry (mCh) was fused to 456 
the C-terminus of mouse Nfasc186 cDNA and subcloned into pCMV5a. Dendra2 457 
(Evrogen, (Gurskaya et al., 2006)) was fused to the C-terminus of the full-length Nfasc186 458 
and cloned into the pCMV5a vector. The following plasmids were gifts: AnkG-mCh 459 
(Leterrier et al., 2011), SEP-Kv7.3, Kv7.2 (Benned-Jensen et al., 2016) KHC560-halo 460 
(Twelvetrees et al., 2016). The constructs were expressed by transient transfection using 461 
Lipofectamine 2000 Transfection Reagent (Life Technologies). 462 
 463 
Live cell imaging 464 
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Live-imaging was performed using an inverted wide-field microscope (Zeiss Axio 465 
Observer), equipped with the following objectives: Plan Apochromat 20X (NA 0.8; 466 
Zeiss), Plan 40X oil (NA 1.3; Zeiss), Plan Apochromat 63X oil (NA 1.4; Zeiss), Alpha 467 
Plan Apochromat 100X oil (NA 1.46; Zeiss), together with Definite Focus.2 (for Z-drift 468 
correction), an ORCA-Flash4.0 V2 Digital CMOS camera (Hamamatsu Photonics) 469 
and a 37˚C imaging chamber (PeCon) in a humidified atmosphere containing 5% 470 
CO2. LED illumination (Colibri 7, Zeiss) was used for image acquisition and camera 471 
pixel size was binned to 2x2 to achieve better signal-to-noise ratios. The entire 472 
imaging workflow was controlled by Zeiss imaging software (ZEN 2.3 blue edition). In 473 
order to perform photomanipulation, the microscope was coupled to two diode lasers (473 474 
nm and 405 nm) and a laser scanning device (UGA-42 Firefly, Rapp OptoElectronic). 475 
Lasers were controlled using SysCon software, synchronised to image acquisition by ZEN 476 
2.3. For experiments utilising SEP-Nfasc186, SEP-Nfasc186YA and SEP-Kv7.3 the 477 
medium was replaced with SEP imaging medium (140 mM NaCl, 5mM KCl, 15 mM D-478 
glucose, 1.5 mM CaCl2, 1.5 mM MgCl2, 20 mM HEPES, pH 7.4). An acidic SEP imaging 479 
medium was used to quench surface fluorescence in which MEM replaced HEPES and the 480 
pH adjusted to 6.0. To allow subsequent recovery of SEP fluorescence the medium was 481 
changed to 50 mM NH4Cl, 90 mM NaCl, 5 mM KCl, 15 mM glucose, 1.8 mM CaCl2, 0.8 482 
mM MgCl2, 20 mM HEPES, pH 7.4. The culture medium for experiments utilising 483 
Nfasc186-Dendra2 was Hibernate-A-Low Fluorescence medium (BrainBits) supplemented 484 
with 2% B27 and 1% GlutaMAX (Hibernate-A imaging medium). 485 
Kinesin560-halo (KHC560-halo) was expressed in neurons at DIV 2–3 either 486 
with SEP-Nfasc186 or in combination with SEP-Kv.7.3 and Kv7.2. The axon terminal 487 
was identified by expression of KHC560-halo visualised by incubating the neurons with the 488 
halo-ligand conjugated to Janelia Fluor-549 fluorophore (100 nM) (JF549-HaloTag Ligand) 489 
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(Grimm et al., 2017) for 10 min at 37°C followed by washes with SEP imaging medium. 490 
Unless specified otherwise, transfected neurons were imaged 491 
using low LED power (10%) for 5 min at 1 s intervals with a 100 ms exposure time. 492 
 493 
Fluorescence recovery after photobleaching 494 
For fluorescence recovery after photobleaching (FRAP) experiments, cortical 495 
neurons were cotransfected at DIV 3–4 or DIV 10–11 with cDNAs encoding AnkG-mCh 496 
with either SEP-Nfasc186 or SEP-Nfasc186YA. The AIS was identified by AnkG-mCh 497 
expression after ~36 h. Imaging was performed at 37˚C using the SEP imaging medium. A 498 
region of the AIS  was photobleached using a 473 nm laser (50% for ~500 ms). Pre-bleach 499 
and post-bleach frames were acquired at the rate of 1 frame every 2 s for 10 s and 10 min, 500 
respectively. Axonal FRAP experiments were conducted using the same experimental 501 
parameters except post-bleaching acquisition was for 5 min. 502 
 503 
Fluorescence loss in photobleaching (FLIP) 504 
Neurons were transfected either with SEP-Nfasc186 or in combination with SEP-Kv.7.3 505 
and Kv7.2. An area proximal to the axon terminal was repeatedly photobleached as 506 
described below and imaged at intervals of 2 s for 5 min. A low laser power setting 507 
(15%,100 ms) was used to avoid phototoxicity. 508 
 509 
FRAP-FLIP 510 
The FRAP-FLIP protocol was adapted from the method previously described by 511 
Henley and colleagues (Hildick et al., 2012). SEP-Nfasc186 and AnkG-mCh were 512 
co-expressed in cortical neurons by transfection at DIV 3–4 and experiments were 513 
performed at DIV 5–6. For FRAP, a single region of interest (ROI) within the AIS was 514 
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photobleached as described above and allowed to recover for 10 min; During this 515 
period of acquisition two flanking ROIs were repeatedly photobleached using the 473-nm 516 
laser (15% for ~100 ms) to achieve effective photobleaching and imaged at intervals of 2 517 
s. Laser power settings for the FRAP-FLIP experiments were carefully evaluated to ensure 518 
neuron viability was not compromised as evaluated by the recovery of the fluorescent 519 
signal at the FLIP-ROI 15 min after the end of the experiment. Axonal FRAP-FLIP 520 
experiments were conducted using the same experimental parameters except post-521 
bleaching acquisition was for 5 min. 522 
 523 
Photoconversion 524 
Neurons were transfected with Nfasc186-Dendra2 cDNA at DIV 3–4 and live cell 525 
imaging was performed in Hibernate-A imaging medium 16–20 h after 526 
transfection. A 40X objective was used to identify transfected neurons (green 527 
fluorescence). Photoconversion was performed either at the soma or axon terminal 528 
using a low laser power with a wavelength of 405 nm (1–2%), with 5–6 exposures, 529 
each with a duration of ~700 ms. Once the selected area was converted, the axon 530 
was imaged using the 63X objective, a multiband pass filter (Chroma Technology 531 
Corp) and LED illumination. Images were acquired every 30 s for 15 min (terminal) 532 
or 30 min (soma). To assess the consequence of disrupting microtubules, photoconversion 533 
was performed after incubation with 20 µM nocodazole in DMSO for 1 h, and control cells 534 
received DMSO alone. 535 
 536 
Vesicle trafficking 537 
For studies on vesicle tracking, neurons at DIV 3–4 were transfected with either Nfasc186-538 
mCh or Nfasc186-Dendra2 cDNA. After 16–20 h of transfection, live cell imaging was 539 
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performed in Hibernate-A imaging medium. Images were recorded every 500 ms with the 540 
100X (NA 1.46) objective and an exposure time of 100 ms. Vesicle movement was 541 
analysed using kymographs generated by an ImageJ plugin KymoToolBox (Zala et al., 542 
2013). The kymographs were manually traced to obtain vesicle speed. 543 
 544 
TIRF microscopy 545 
Neurons were cultured on 35 mm glass-bottom dishes (170 ± 5 µm thickness, ibidi) and 546 
cotransfected with SEP-Nfasc186 and KHC560-halo cDNAs at DIV 3. Imaging was 547 
performed 16–18 h after transfection. To visualise axon terminals JF 549 548 
Halo Tag Ligand was first added to the neurons for 10 min.   549 
SEP imaging media was added to the cultures after washing. TIRF experiments 550 
were conducted using an inverted Zeiss TIRF III microscope with a 488-nm laser, a 551 
100X Alpha Plan Apochromat oil immersion objective (NA 1.46, Zeiss) and TIRF III 552 
motorised slider in a closed environmental chamber at 37˚C. The illumination angle 553 
was set for evanescent illumination (~ 110 nm) (Axelrod, 2001). Images were 554 
acquired with a Photometrics Evolve Delta EMCCD camera every 50 ms for 1—2 min, 555 
using Zen Blue 2.3 software. 556 
 557 
Drug treatments 558 
The myosin II ATPase inhibitor Blebbistatin (20 µM, (S)-nitro-Blebbistatin) was 559 
added to the neuronal cultures for ~20 h before FRAP experiments. Cortical neurons were 560 
treated with latrunculin A (5 µM) for 1 h before FRAP experiments. Nocodazole treatment 561 




Cultured cortical neurons were fixed by immersion in 4% paraformaldehyde (PFA) in 0.1 M 565 
sodium phosphate buffer (pH 7.4) for 15 min at room temperature, followed by three 566 
washes in PBS. Brains from WT and L7-SEP-Nfasc186 mice at P10 were fixed by 567 
transcardial perfusion with 4% PFA in 0.1 M sodium phosphate buffer (pH 7.4) as 568 
described previously (Tait et al., 2000). Brains were postfixed for 30 min with 4% PFA in 569 
0.1 M sodium phosphate buffer, followed by three washes in PBS.  Parasagittal vibratome 570 
sections (100 µm) were cut. Fixed samples were blocked (cortical neurons for 30 min, 571 
cerebellar slices for 1 h) in blocking buffer containing 5% fish skin gelatin, and Triton X-100 572 
(cortical neurons 0.2%, cerebellar slices 0.5%) in PBS followed by incubation with primary 573 
antibodies for 2 h or overnight. Primary antibodies were diluted in 5% fish skin gelatin for 574 
cortical neurons and in blocking buffer for cerebellar slices. Primary antibodies used in the 575 
study are: GFP, ßIV spectrin (Zonta et al., 2011), AnkyrinG and Neurofascin (intracellular 576 
(Tait et al., 2000)). For surface labelling of Neurofascin, live cells were incubated with anti-577 
Neurofascin (extracellular) antibody (diluted in the neurobasal culture media) for 30 min at 578 
37˚C followed by fixation and further staining with Alexa Fluor 568-conjugated phalloidin 579 
(1:200, Invitrogen) and secondary antibodies. The Alexa Fluor conjugated secondary 580 
antibodies were diluted in 5% fish skin gelatin for cortical neurons and in blocking buffer 581 
for cerebellar slices and were incubated for 2 h. Samples were mounted in Vectashield 582 
Mounting Medium (Vector Laboratories). For AIS intensity analysis, cortical neuron images 583 
were acquired on a Zeiss Axio Observer with a 63X objective lens. Representative images 584 
were acquired on a Zeiss LSM710 confocal microscope with a Plan Apochromat 63X oil 585 
objective (NA 1.4; Zeiss). Images from cerebellar slices were acquired on a Leica TCL-SL 586 




Quantification and statistical analysis 590 
FIJI was used to view and analyse images and videos. The intensity profile and total 591 
signal intensity of the AIS and distal axons were measured in FIJI. For FRAP and FRAP-592 
FLIP analysis, the mean fluorescence intensity of the bleached region was normalised to 593 
the intensity of the pre-bleached region and plotted as a fraction after background 594 
correction of all frames. The normalised data were fitted with a single-exponential equation 595 
to extract the recovery fraction after photobleaching. The diffusion coefficient was 596 
estimated by fitting the recovery data to a one-dimensional diffusion model (Ellenberg and 597 
Lippincott-Schwartz, 1999). For FLIP analysis at the axon terminus, an ROI was selected 598 
proximal to the bleaching region; the average signal intensity of each frame was measured 599 
and plotted as a fraction of the initial signal intensity before imaging. 600 
In order to quantify Nfasc186-Dendra2 movement to the axon, an ROI was 601 
selected in the axon. The ROI was at a constant distance from the axon terminal to allow 602 
comparison between different experiments. The average signal intensity of the ROI in 603 
each frame was measured and plotted as a fraction of the peak signal intensity. 604 
All data are represented as mean ± SEM unless otherwise mentioned in the figure 605 
legends. Statistical analyses were performed using GraphPad Prism version 6.0 software. 606 
Statistical significance was analysed by two-tailed Student’s t-test or one-way ANOVA 607 
followed by Tukey’s multiple comparisons test. n values are reported in the corresponding 608 
figure legends. The sample size was determined based on similar studies within the field. 609 
A p-value <0.05 was considered statistically significant. 610 
611 
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 822 
VIDEO LEGENDS 823 
Video 1. TIRF microscopy imaging of SEP-Nfasc186 vesicle fusion events at the cell 824 
surface of the soma (top) and axon terminal (lower). The dashed lines outline the cell body 825 
and axon terminal respectively. Arrowheads point to some individual fusion events. Real 826 
interframe interval, 50 ms. Scale bar, 5 µm. 827 
 828 
Video 2. FLIP of SEP-Nfasc186 in the distal axon proximal to the axon terminus. SEP-829 
Nfasc186 fluorescence signal is depleted in the axon (arrows) proximal to the ROI 830 
(outlined by the box) following FLIP (top) and at the axon terminal itself showing that SEP-831 
Nfasc186 moves retrogradely from and anterogradely to the axon terminus. The lower 832 
movie shows no significant bleaching of a control axon during the same acquisition period. 833 
Real interframe interval, 2 s. Scale bar, 5 µm. 834 
 835 
Video 3. Imaging of cortical neurons expressing Nfasc186-Dendra2 after photoconversion 836 
at the axon terminal. The photoconverted signal is propagated from the axon terminal to 837 
 41 
the distal axon (shown by arrows) in the absence (top) or presence of nocodazole (lower). 838 
Real interframe interval, 30 s. Scale bar, 5 µm. 839 
 840 
Video 4. Transport of Nfasc186-mCh in axonal vesicles in rat cortical axons. Arrows 841 
indicate the directionality of movement. Kymograph analysis of 5 axons showed that the 842 
anterograde velocity was 2.3  0.27 m/s and retrograde velocity was 1.9 ± 0.18 m/s 843 
(mean  SEM). Real interframe interval, 0.5 s. Scale bar, 5 m. 844 
 845 
 846 
Video 5. FRAP (top) and FRAP-FLIP (lower) at the AIS of cortical neurons expressing 847 
SEP-Nfasc186 (DIV 5). The boxes indicate the FRAP ROI and the flanking FLIP ROIs. 848 
Real interframe interval, 2 s. Scale bar, 2 µm. 849 
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